Activity Description & Educational Objectives
This educational activity based on a recent live webcast is designed to improve participants’ knowledge and skill in providing individualized, goal-oriented care to patients with ACS. Through a combination of case-based discussions and focused assessments of current evidence, an expert in the field offers guidance on applying best practices for ACS risk assessment, treatment planning, and delivery of care to patients with ACS, from emergency to inpatient care.
Upon completion of this activity, participants will be able to:
- Critically evaluate recent advances in the treatment of ACS, including the efficacy, safety, and pharmacokinetics of oral antiplatelet therapy
- Implement oral antiplatelet therapy based on patient characteristics, evidence-based guidelines, and recent clinical trial findings
- Design evidence-based, guideline-directed, goal-oriented personalized treatment plans for patients with ACS
- Outline strategies to improve the transition of patients with ACS from emergency to inpatient care
This activity has been designed to meet the educational needs of cardiologists, hospitalists, ER physicians, ER nurses, and other clinicians involved in the management of ACS.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Release and Expiration Dates: March 24, 2014 - March 23, 2015
Time to Complete: 60 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Course Director and Moderator
Deepak L. Bhatt, MD, MPH
Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital Heart and Vascular Center
Professor of Medicine
Harvard Medical School
Deepak L. Bhatt, MD, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant for Regado Biosciences.
Grant/Research Support from Amarin Corp.; AstraZeneca; Bristol-Myers Squibb; Eisai Inc.; Ethicon Endo-Surgery, Inc.; Hoffmann-La Roche Inc.; Medtronic, Inc.; sanofi-aventis; and The Medicines Company.
Honoraria from American College of Cardiology (Editor, Clinical Trials, Cardiosource); Belvoir Publications (Editor in Chief, Harvard Heart Letter); Duke Clinical Research Institute (clinical trial steering committees); Harvard Clinical Research Institute (clinical trial steering committee); HMP Communications (Editor in Chief, Journal of Invasive Cardiology); Population Health Research Institute (clinical trial steering committee); Slack Publications (Chief Medical Editor, Cardiology Today’s Intervention); and WebMD (CME steering committees).
Advisory Board for Elsevier Inc.; Medscape Cardiology; and Regado Biosciences.
Other Financial or Material Support from Board of Directors: Boston VA Research Institute; Society of Cardiovascular Patient Care; and Chair: American Heart Association Get With The Guidelines Steering Committee. Data Monitoring Committees: Duke Clinical Research Institute; Harvard Clinical Research Institute; Mayo Clinic; and Population Health Research Institute. Unfunded Research for FlowCo; PLx Pharma; and Takeda Pharmaceutical Company Limited.
Christopher Washburn, PhD
PVI, PeerView Institute for Medical Education
Christopher Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.
Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.
Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5514-14-T.
The Institute for Advancement of Human Behavior is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This course is co-provided by IAHB and PVI, PeerView Institute for Medical Education. Maximum of 1.0 contact hour(s).
This CME/CNE activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education; the activity is also co-provided by the Institute for Advancement of Human Behavior.
This activity is supported by an independent educational grant from
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.